143 related articles for article (PubMed ID: 25338620)
21. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
22. Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors.
Gubbels JA; Belisle J; Onda M; Rancourt C; Migneault M; Ho M; Bera TK; Connor J; Sathyanarayana BK; Lee B; Pastan I; Patankar MS
Mol Cancer; 2006 Oct; 5(1):50. PubMed ID: 17067392
[TBL] [Abstract][Full Text] [Related]
23. MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse.
Wang Y; Cheon DJ; Lu Z; Cunningham SL; Chen CM; Luo RZ; Xing D; Orsulic S; Bast RC; Behringer RR
Differentiation; 2008 Dec; 76(10):1081-92. PubMed ID: 18637025
[TBL] [Abstract][Full Text] [Related]
24. MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.
Giannakouros P; Comamala M; Matte I; Rancourt C; Piché A
Am J Cancer Res; 2015; 5(1):219-30. PubMed ID: 25628932
[TBL] [Abstract][Full Text] [Related]
25. CA125/MUC16 is dispensable for mouse development and reproduction.
Cheon DJ; Wang Y; Deng JM; Lu Z; Xiao L; Chen CM; Bast RC; Behringer RR
PLoS One; 2009; 4(3):e4675. PubMed ID: 19262696
[TBL] [Abstract][Full Text] [Related]
26. Osteopontin is an oncogenic Vav1- but not wild-type Vav1-responsive gene: implications for fibroblast transformation.
Schapira V; Lazer G; Katzav S
Cancer Res; 2006 Jun; 66(12):6183-91. PubMed ID: 16778192
[TBL] [Abstract][Full Text] [Related]
27. Ectopic expression of PTTG1/securin promotes tumorigenesis in human embryonic kidney cells.
Hamid T; Malik MT; Kakar SS
Mol Cancer; 2005 Jan; 4(1):3. PubMed ID: 15649325
[TBL] [Abstract][Full Text] [Related]
28. Human kallikrein related peptidases 6 and 13 in combination withCA125 is a more sensitive test for ovarian cancer than CA125 alone.
White NM; Mathews M; Yousef GM; Prizada A; Fontaine D; Ghatage P; Popadiuk C; Dawson L; Doré JJ
Cancer Biomark; 2009; 5(6):279-87. PubMed ID: 20037204
[TBL] [Abstract][Full Text] [Related]
29. Thrombospondin-1 suppresses tumorigenesis and angiogenesis in serum- and anchorage-independent NIH 3T3 cells.
Castle VP; Dixit VM; Polverini PJ
Lab Invest; 1997 Jul; 77(1):51-61. PubMed ID: 9251678
[TBL] [Abstract][Full Text] [Related]
30. Characterization of binding epitopes of CA125 monoclonal antibodies.
Marcos-Silva L; Narimatsu Y; Halim A; Campos D; Yang Z; Tarp MA; Pereira PJ; Mandel U; Bennett EP; Vakhrushev SY; Levery SB; David L; Clausen H
J Proteome Res; 2014 Jul; 13(7):3349-59. PubMed ID: 24850311
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic Ras-mediated downregulation of Clast1/LR8 is involved in Ras-mediated neoplastic transformation and tumorigenesis in NIH3T3 cells.
Ryu SH; Kim KH; Kim HB; Kim MH; Kim NH; Kang Y; Hyun JW; Seo HJ; Jun JY; You HJ
Cancer Sci; 2010 Sep; 101(9):1990-6. PubMed ID: 20550525
[TBL] [Abstract][Full Text] [Related]
32. MUC16: molecular analysis and its functional implications in benign and malignant conditions.
Haridas D; Ponnusamy MP; Chugh S; Lakshmanan I; Seshacharyulu P; Batra SK
FASEB J; 2014 Oct; 28(10):4183-99. PubMed ID: 25002120
[TBL] [Abstract][Full Text] [Related]
33. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
Woo RA; Poon RY
Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
[TBL] [Abstract][Full Text] [Related]
34. Introducing the MUC16 gene: implications for prevention and early detection in epithelial ovarian cancer.
McLemore MR; Aouizerat B
Biol Res Nurs; 2005 Apr; 6(4):262-7. PubMed ID: 15788735
[TBL] [Abstract][Full Text] [Related]
35. MUC16 as a novel target for cancer therapy.
Aithal A; Rauth S; Kshirsagar P; Shah A; Lakshmanan I; Junker WM; Jain M; Ponnusamy MP; Batra SK
Expert Opin Ther Targets; 2018 Aug; 22(8):675-686. PubMed ID: 29999426
[TBL] [Abstract][Full Text] [Related]
36. [Overexpression of EDAG-1 in NIH3T3 cells leads to malignant transformation].
Lü J; Xu WX; Wang SY; Jiang Y; Li CY; Cai WM; Yang XM
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Jan; 34(1):95-8. PubMed ID: 11958143
[TBL] [Abstract][Full Text] [Related]
37. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation.
Nemieboka B; Sharma SK; Rao TD; Edwards KJ; Yan S; Wang P; Ragupathi A; Piersigilli A; Spriggs DR; Lewis JS
Nucl Med Biol; 2020; 86-87():9-19. PubMed ID: 32403071
[TBL] [Abstract][Full Text] [Related]
38. A novel monoclonal antibody to a defined peptide epitope in MUC16.
Marcos-Silva L; Ricardo S; Chen K; Blixt O; Arigi E; Pereira D; Høgdall E; Mandel U; Bennett EP; Vakhrushev SY; David L; Clausen H
Glycobiology; 2015 Nov; 25(11):1172-82. PubMed ID: 26201951
[TBL] [Abstract][Full Text] [Related]
39. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.
Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D
Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380
[TBL] [Abstract][Full Text] [Related]
40. A binding domain on mesothelin for CA125/MUC16.
Kaneko O; Gong L; Zhang J; Hansen JK; Hassan R; Lee B; Ho M
J Biol Chem; 2009 Feb; 284(6):3739-49. PubMed ID: 19075018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
